CYGENTA (China) Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 7

CYGENTA (China) General Information

Description

Provider of contract development and manufacturing services designed for cell and gene therapy applications. The company offers a full-process service platform encompassing early development, investigational new drug (IND) registration, clinical trials, and commercialization, with capabilities in plasmid production, viral vector manufacturing, cell processing, and comprehensive quality control analysis; enabling biotechnology and pharmaceutical companies to streamline the development and production of advanced therapeutic products.

Contact Information

Website
www.cgtcdmo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 1, No. 7 Tiangui Street
  • Biomedical Base, Daxing District
  • Beijing
  • China
+86 010
Primary Industry
BPO/Outsource Services
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Corporate Office
  • Building 1, No. 7 Tiangui Street
  • Biomedical Base, Daxing District
  • Beijing
  • China
+86 010

CYGENTA (China) Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CYGENTA (China) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 21-Jan-2025 Completed Generating Revenue
2. Early Stage VC 07-Jul-2023 Completed Generating Revenue
1. Early Stage VC 25-Oct-2022 $4.32M Completed Generating Revenue
To view CYGENTA (China)’s complete valuation and funding history, request access »

CYGENTA (China) Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innoangel Fund Venture Capital Minority
Lhasa Anchao Investment Management Venture Capital Minority
SJ Jiacheng Investment Management Corporate Venture Capital Minority
Tsingyuan Capital Venture Capital Minority
Momentum Venture Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

CYGENTA (China) FAQs

  • When was CYGENTA (China) founded?

    CYGENTA (China) was founded in 2022.

  • Where is CYGENTA (China) headquartered?

    CYGENTA (China) is headquartered in Beijing, China.

  • What industry is CYGENTA (China) in?

    CYGENTA (China)’s primary industry is BPO/Outsource Services.

  • Is CYGENTA (China) a private or public company?

    CYGENTA (China) is a Private company.

  • What is CYGENTA (China)’s current revenue?

    The current revenue for CYGENTA (China) is .

  • Who are CYGENTA (China)’s investors?

    Innoangel Fund, Lhasa Anchao Investment Management, SJ Jiacheng Investment Management, Tsingyuan Capital, and Momentum Venture are 5 of 7 investors who have invested in CYGENTA (China).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process